Larry M Gordon

USPTO Granted Patents = 9 (Patent Applications = 5)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 22(Granted Patents)

Location History:

Del Mar, CA (US) (2003 - 2009)
Torrance, CA (US) (2013 - 2024)

Company Filing History:

5 out of 83

Los Angeles Biomedical Research Institute at Harbor-ucla Medical Center

patents

4 out of 975

University of Rochester

patents

2 out of 10

The Lundquist Institute for Biomedical Innovation at Harbor-ucla Medical Center

Harbor-ucla Research and Education Institute

patents

6. 1 out of 1

Lindquist Institute for Biomedical Innovation at Harbor-ucla Medical Center

patent

where one patent can have more than one assignee

Years Active: 2003-2024

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11951158 - Compositions and methods for administering PPARγ agonists, surfactant peptides and phospholipids (2024-04-09),

2. 11179446 - Compositions and method for administering PPARgamma agonists, surfactant peptides and phosopholipids (2021-11-23),

3. 10717777 - Synthetic lung surfactant with enhanced stability and effectiveness (2020-07-21),

4. 10358465 - SP-B and SP-C peptides, synthetic lung surfactants, and use thereof (2019-07-23),

5. 9815869 - SP-B and SP-C peptides, synthetic lung surfactants, and use thereof (2017-11-14),

6. 9447127 - Synthetic lung surfactant and use thereof (2016-09-20),

7. 8563683 - Synthetic lung surfactant and use thereof (2013-10-22),

8. 7538090 - Exogenous surfactant protein B mimic (2009-05-26),

9. 6660833 - Respiratory distress syndrome therapy with peptide analogs of human SP-B (2003-12-09),

Title: Innovations by Larry M. Gordon: Pioneering Compositions for Lung Health

Introduction

Larry M. Gordon, an inventive mind based in Torrance, CA, has made significant strides in the field of medical research, particularly in compositions for lung health. With a portfolio of nine patents, Gordon has demonstrated a commitment to advancing therapies that can improve outcomes for patients with respiratory challenges.

Latest Patents

Among his notable contributions are compositions and methods for administering PPARγ agonists, surfactant peptides, and phospholipids. These innovative therapies target the symptoms and disorders associated with insufficient surfactant production and hyperoxia. One embodiment of his work details formulations intended for aerosol delivery during ventilation therapy. The compositions aim to reduce the likelihood of developing or the severity of Respiratory Distress Syndrome (RDS) in infants, while also promoting lung maturation in hyperoxic environments.

Career Highlights

Gordon's career includes significant positions at reputable institutions, such as the University of Rochester and the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. His work in these organizations has been instrumental in developing advanced therapeutic methods and compositions that cater to critical health needs.

Collaborations

Larry M. Gordon has collaborated with distinguished colleagues in the field, including Frans J. Walther and Alan J. Waring. These partnerships have enriched the research and development process, fostering innovation and enhancing the potential benefits of their combined expertise.

Conclusion

Larry M. Gordon's contributions to medical innovation underscore the importance of research in improving health outcomes. His patents reflect not only a deep understanding of medical needs but also a drive to create effective solutions for complex respiratory challenges. Through his work, Gordon continues to inspire future innovations that can significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.